Human Cytomegalovirus Envelope Glycoprotein B Market Report

Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 18, 2020
  • PAGES：210
  • REPORT CODE：GMM476286
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Human Cytomegalovirus Envelope Glycoprotein B market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.0% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Human Cytomegalovirus Envelope Glycoprotein B Market Segmentations:

    By Player:

    • VBI Vaccine Inc.

    • Astellas Pharma Inc

    • Vakzine Projekt Management GmbH.

    • Trellis Bioscience, Inc

    • Vical Incorporated

    By Type:

    • CSJ-148

    • CyMVectin

    • TRL-345

    • PPCM

    • Cytomegalovirus Vaccine

    • Others

    By End-User:

    • Infectious Disease

    • Oncology

    • Women's Health

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Cytomegalovirus Envelope Glycoprotein B Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of CSJ-148 from 2014 to 2026

    • 1.3.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of CyMVectin from 2014 to 2026

    • 1.3.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of TRL-345 from 2014 to 2026

    • 1.3.4 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of PPCM from 2014 to 2026

    • 1.3.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Cytomegalovirus Vaccine from 2014 to 2026

    • 1.3.6 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Infectious Disease from 2014 to 2026

    • 1.4.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Oncology from 2014 to 2026

    • 1.4.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Women's Health from 2014 to 2026

    • 1.4.4 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Human Cytomegalovirus Envelope Glycoprotein B Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Human Cytomegalovirus Envelope Glycoprotein B by Major Types

      • 3.4.1 Market Size and Growth Rate of CSJ-148

      • 3.4.2 Market Size and Growth Rate of CyMVectin

      • 3.4.3 Market Size and Growth Rate of TRL-345

      • 3.4.4 Market Size and Growth Rate of PPCM

      • 3.4.5 Market Size and Growth Rate of Cytomegalovirus Vaccine

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Human Cytomegalovirus Envelope Glycoprotein B Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Human Cytomegalovirus Envelope Glycoprotein B by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Human Cytomegalovirus Envelope Glycoprotein B for Infectious Disease

      • 4.4.2 Market Size and Growth Rate of Human Cytomegalovirus Envelope Glycoprotein B for Oncology

      • 4.4.3 Market Size and Growth Rate of Human Cytomegalovirus Envelope Glycoprotein B for Women's Health

      • 4.4.4 Market Size and Growth Rate of Human Cytomegalovirus Envelope Glycoprotein B for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Production Analysis by Top Regions

    • 5.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Analysis by Top Regions

    • 5.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.3 France Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    6 Product Circulation of Human Cytomegalovirus Envelope Glycoprotein B Market among Top Countries

    • 6.1 Top 5 Export Countries in Human Cytomegalovirus Envelope Glycoprotein B Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Human Cytomegalovirus Envelope Glycoprotein B Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Human Cytomegalovirus Envelope Glycoprotein B Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Human Cytomegalovirus Envelope Glycoprotein B Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Human Cytomegalovirus Envelope Glycoprotein B Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Human Cytomegalovirus Envelope Glycoprotein B Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 7.1 Germany Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 7.2 Germany Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    8. UK Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 8.1 UK Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 8.2 UK Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    9. France Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 9.1 France Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 9.2 France Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    10. Italy Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 10.1 Italy Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 10.2 Italy Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    11. Spain Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 11.1 Spain Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 11.2 Spain Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    12. Poland Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 12.1 Poland Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 12.2 Poland Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    13. Russia Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 13.1 Russia Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 13.2 Russia Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    14. Switzerland Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 14.1 Switzerland Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 14.2 Switzerland Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    15. Turkey Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 15.1 Turkey Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 15.2 Turkey Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Top Countries

      • 16.3.1 Denmark Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 16.3.2 Finland Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 16.3.3 Norway Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 16.3.4 Sweden Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 16.3.6 Iceland Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Top Countries

      • 17.3.1 Belgium Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 17.3.2 Netherlands Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 17.3.3 Luxembourg Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Top Countries

      • 18.3.1 Estonia Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 18.3.2 Latvia Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 18.3.3 Lithuania Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 VBI Vaccine Inc.

      • 19.1.1 VBI Vaccine Inc. Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Astellas Pharma Inc

      • 19.2.1 Astellas Pharma Inc Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Vakzine Projekt Management GmbH.

      • 19.3.1 Vakzine Projekt Management GmbH. Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Trellis Bioscience, Inc

      • 19.4.1 Trellis Bioscience, Inc Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Vical Incorporated

      • 19.5.1 Vical Incorporated Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    The List of Tables and Figures (Totals 71 Figures and 155 Tables)

    • Figure Product Picture

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of CSJ-148 from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of CyMVectin from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of TRL-345 from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of PPCM from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Cytomegalovirus Vaccine from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Infectious Disease from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Women's Health from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure UK Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure France Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Human Cytomegalovirus Envelope Glycoprotein B Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Human Cytomegalovirus Envelope Glycoprotein B

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Human Cytomegalovirus Envelope Glycoprotein B by Different Types from 2014 to 2026

    • Table Consumption Share of Human Cytomegalovirus Envelope Glycoprotein B by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of CSJ-148

    • Figure Market Size and Growth Rate of CyMVectin

    • Figure Market Size and Growth Rate of TRL-345

    • Figure Market Size and Growth Rate of PPCM

    • Figure Market Size and Growth Rate of Cytomegalovirus Vaccine

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Human Cytomegalovirus Envelope Glycoprotein B by Different End-Users from 2014 to 2026

    • Table Consumption Share of Human Cytomegalovirus Envelope Glycoprotein B by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Infectious Disease

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Women's Health

    • Figure Market Size and Growth Rate of Others

    • Table Europe Human Cytomegalovirus Envelope Glycoprotein B Production by Major Regions

    • Table Europe Human Cytomegalovirus Envelope Glycoprotein B Production Share by Major Regions

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Production Share by Major Countries and Regions in 2014

    • Table Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption by Major Regions

    • Table Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Regions

    • Table Germany Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table UK Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table France Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Italy Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Spain Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Poland Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Russia Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Switzerland Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Turkey Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Human Cytomegalovirus Envelope Glycoprotein B Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Human Cytomegalovirus Envelope Glycoprotein B Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Human Cytomegalovirus Envelope Glycoprotein B Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Human Cytomegalovirus Envelope Glycoprotein B Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Germany Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table Germany Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Germany Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table UK Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table UK Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table UK Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table UK Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table France Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table France Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table France Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table France Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table Italy Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Italy Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table Italy Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Italy Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table Spain Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Spain Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table Spain Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Spain Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table Poland Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Poland Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table Poland Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Poland Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table Russia Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Russia Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table Russia Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Russia Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Switzerland Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table Switzerland Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Switzerland Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Turkey Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table Turkey Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Turkey Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of VBI Vaccine Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of VBI Vaccine Inc.

    • Figure Sales and Growth Rate Analysis of VBI Vaccine Inc.

    • Figure Revenue and Market Share Analysis of VBI Vaccine Inc.

    • Table Product and Service Introduction of VBI Vaccine Inc.

    • Table Company Profile and Development Status of Astellas Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc

    • Figure Sales and Growth Rate Analysis of Astellas Pharma Inc

    • Figure Revenue and Market Share Analysis of Astellas Pharma Inc

    • Table Product and Service Introduction of Astellas Pharma Inc

    • Table Company Profile and Development Status of Vakzine Projekt Management GmbH.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vakzine Projekt Management GmbH.

    • Figure Sales and Growth Rate Analysis of Vakzine Projekt Management GmbH.

    • Figure Revenue and Market Share Analysis of Vakzine Projekt Management GmbH.

    • Table Product and Service Introduction of Vakzine Projekt Management GmbH.

    • Table Company Profile and Development Status of Trellis Bioscience, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Trellis Bioscience, Inc

    • Figure Sales and Growth Rate Analysis of Trellis Bioscience, Inc

    • Figure Revenue and Market Share Analysis of Trellis Bioscience, Inc

    • Table Product and Service Introduction of Trellis Bioscience, Inc

    • Table Company Profile and Development Status of Vical Incorporated

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vical Incorporated

    • Figure Sales and Growth Rate Analysis of Vical Incorporated

    • Figure Revenue and Market Share Analysis of Vical Incorporated

    • Table Product and Service Introduction of Vical Incorporated

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US